oxybutynin has been researched along with Urinary Retention in 5 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the anticholinergic dosage was low, the present results suggest that naftopidil monotherapy was as useful as combination therapy of naftopidil and an anticholinergic agent." | 6.72 | Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study. ( Hanazawa, K; Honda, S; Kawachi, Y; Koizumi, K; Maruyama, O; Noto, K; Saitoh, T; Sugimura, S; Sugiyama, Y; Yamashita, R, 2006) |
| "To evaluate the symptomatic and urodynamic effects of oxybutynin in the control of irritative micturitional symptoms during the first week after transurethral resection of benign prostatic hyperplasia (BPH)." | 5.08 | Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate. ( Borst, F; Graber, P; Iselin, CE; Rohner, S; Schmidlin, F, 1997) |
| "Although the anticholinergic dosage was low, the present results suggest that naftopidil monotherapy was as useful as combination therapy of naftopidil and an anticholinergic agent." | 2.72 | Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study. ( Hanazawa, K; Honda, S; Kawachi, Y; Koizumi, K; Maruyama, O; Noto, K; Saitoh, T; Sugimura, S; Sugiyama, Y; Yamashita, R, 2006) |
| "Fentanyl is a potent synthetic opioid with a variety of possible applications." | 1.51 | Fatal misuse of transdermal fentanyl patches. ( Doberentz, E; Geile, J; Kraemer, M; Maas, A; Madea, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hobaika, AB | 1 |
| Maruyama, O | 1 |
| Kawachi, Y | 1 |
| Hanazawa, K | 1 |
| Koizumi, K | 1 |
| Yamashita, R | 1 |
| Sugimura, S | 1 |
| Honda, S | 1 |
| Sugiyama, Y | 1 |
| Saitoh, T | 1 |
| Noto, K | 1 |
| Iselin, CE | 1 |
| Schmidlin, F | 1 |
| Borst, F | 1 |
| Rohner, S | 1 |
| Graber, P | 1 |
| Kelleher, CJ | 1 |
| Cardozo, LD | 1 |
| Khullar, V | 1 |
| Salvatore, S | 1 |
| Geile, J | 1 |
| Maas, A | 1 |
| Kraemer, M | 1 |
| Doberentz, E | 1 |
| Madea, B | 1 |
2 trials available for oxybutynin and Urinary Retention
| Article | Year |
|---|---|
Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzilates; Cholinergic Antagonists; Drug Therapy, Combination; | 2006 |
Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate.
Topics: Aged; Double-Blind Method; Humans; Male; Mandelic Acids; Middle Aged; Parasympatholytics; Postoperat | 1997 |
3 other studies available for oxybutynin and Urinary Retention
| Article | Year |
|---|---|
Chronic use of oxybutynin and spinal anesthesia: a case of postoperative urinary retention and hematuria.
Topics: Ambulatory Surgical Procedures; Anesthesia, Spinal; Cholinergic Antagonists; Hematuria; Humans; Leg; | 2011 |
A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.
Topics: Adult; Aged; Aged, 80 and over; Cholinergic Antagonists; Exercise Therapy; Female; Humans; Incontine | 1997 |
Fatal misuse of transdermal fentanyl patches.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Chromatography, Liquid; Female; Fentanyl; Hair; Humans; | 2019 |